MAMLD1: A Potential Drug Target and Biomarker (G10046)

Target Name: MAMLD1

NCBI ID: G10046

MAMLD1

MAMLD1: A Potential Drug Target and Biomarker

MAMLD1, or microRNA-like large DNA molecule, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MAMLD1 is a key regulator of gene expression in various cell types and has been shown to play a role in the development and progression of several diseases, including cancer.

The discovery of MAMLD1 as a potential drug target and biomarker has significant implications for the development of new treatments for these diseases. By targeting MAMLD1 with drugs, researchers can reduce the growth of cancer cells and slow down the progression of the disease.

MAMLD1 is a RNA molecule that is approximately 200 nucleotides long and has been shown to play a role in the regulation of gene expression in various cell types. MAMLD1 is produced in high levels in the brain and has been shown to be involved in the development and progression of several diseases, including cancer.

One of the key functions of MAMLD1 is its role as a regulator of microRNA (miRNA) expression. MiRNA is a small non-coding RNA molecule that plays a critical role in the regulation of gene expression in various cell types. MAMLD1 has been shown to work with miRNA to regulate the expression of target genes and is a potential drug target for cancer.

In addition to its role as a regulator of miRNA expression, MAMLD1 has also been shown to play a role in the development of cancer. Studies have shown that MAMLD1 is overexpressed in various types of cancer, including breast, lung, and ovarian cancer. Overexpression of MAMLD1 has been shown to promote the growth and survival of cancer cells, making it a potential biomarker for cancer.

MAMLD1 has also been shown to play a role in the regulation of cellular processes that are important for cancer development. For example, MAMLD1 has been shown to regulate the angiogenesis (the formation of new blood vessels) that is critical for the growth and survival of cancer cells.

In conclusion, MAMLD1 is a potential drug target and biomarker for cancer. Its role as a regulator of miRNA expression and its involvement in the development and progression of cancer make it an attractive target for drug development. Further research is needed to fully understand the role of MAMLD1 in cancer and to develop effective treatments.

Protein Name: Mastermind Like Domain Containing 1

Functions: Transactivates the HES3 promoter independently of NOTCH proteins. HES3 is a non-canonical NOTCH target gene which lacks binding sites for RBPJ

The "MAMLD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAMLD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets